QA: Bristol Myers Squibb CO in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000014272_2023_Bristol_Myers_Squibb_CO.pdf

Logs

Graph

Absolute values for 0000014272, Bristol Myers Squibb CO

  xvar xval
0 AssetsCurrent 27,273,000,000
1 IntangibleAssetsNetIncludingGoodwill 57,008,000,000
2 PropertyPlantAndEquipmentNet 6,255,000,000
3 remainder_Assets 6,284,000,000
4 LiabilitiesCurrent 21,890,000,000
5 LiabilitiesNoncurrent 41,646,000,000
6 remainder_Liabilities 2,166,000,000
7 CostOfGoodsAndServicesSold 10,113,539,681
8 SellingGeneralAndAdministrativeExpense 7,815,695,571
9 ResearchAndDevelopmentExpense 9,691,362,035
10 remainder_Expenses 11,777,666,854
11 remainder_Revenues 46,107,502,921
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 252,568,199
  yvar yval
0 Assets 96,820,000,000
1 Liabilities 65,702,000,000
2 Expenses 39,398,264,141
3 Revenues 46,107,502,921
4 StockholdersEquity 31,118,000,000
5 NetIncome 6,709,238,780
6 ComprehensiveNetIncome 6,835,522,880
7 BaseVar 124,140,167,630
8 EconomicCapitalRatiobeforeLimitedLiability 0.919
9 EconomicCapitalRatio 2.24

Edgar->Model Mapping

Feature Distribution

Change over Time